Progesterone Suppresses Uterine Contraction by Reducing Odontogenic Porphyromonas gingivalis Induced Chronic Inflammation in Mice

Biomolecules. 2022 Jul 26;12(8):1029. doi: 10.3390/biom12081029.

Abstract

Preterm birth is one of the most significant obstetric complications. Inflammation reportedly promotes uterine contraction and weakening of the fetal membrane, which induces preterm birth. Previous studies using animal models of lipopolysaccharide-induced acute inflammation have shown that progesterone (P4) promotes uterine quiescence. However, this effect is not fully understood in chronic inflammation. This study aimed to investigate the effects of P4 on uterine contractility and inflammation of the fetal membrane in mice infected with Porphyromonas gingivalis (P.g.), a major periodontal pathogen as a model of preterm birth caused by chronic inflammation. Mice were injected with 1 mg of P4 from day 15.5 to 17.5. P4 prolonged the mean gestation period of P.g mice from 18.3 to 20.4 days, and no reduction in the gestation period was observed. P4 treatment suppressed spontaneous uterine contractility and decreased oxytocin sensitivity. In addition, the expression of inflammatory cytokines in the fetal membrane was significantly reduced. Thus, P4 prevented preterm birth by suppressing enhanced uterine contractility induced by chronic inflammation in this model. This result describes the effects of P4 in a chronic inflammation model, which may lead to a better understanding of the efficacy of P4 in preventing preterm birth in humans.

Keywords: Porphyromonas gingivalis; chronic inflammation; odontogenic infection; preterm birth; progesterone.

MeSH terms

  • Animals
  • Female
  • Humans
  • Infant, Newborn
  • Inflammation / metabolism
  • Mice
  • Porphyromonas gingivalis
  • Pregnancy
  • Premature Birth* / prevention & control
  • Progesterone / pharmacology
  • Uterine Contraction*

Substances

  • Progesterone

Grants and funding

This research received no external funding.